Biogen stock price
바이오젠NASDAQ:BIIB · Nasdaq · HealthcareToday's signals · Near 52-week high, VCP
Signal details →Biogen last closed at $219.88 (-1.32%) on 2026-10-02. Signals today: Near 52-week high, VCP. Listed on Nasdaq. Trailing 12 months PER is 39.2×. Its overall grade ranks 399 of 739 stocks in Healthcare.
About this company
Biogen last closed at $219.88 (-1.32%) on 2026-10-02. Signals today: Near 52-week high, VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 399/739
Valuation grade F
Related stocks
- EisaiCustomer
알츠하이머 치료제 Leqembi 공동개발·공동상업화 파트너
- RocheCompetitor
신경과학·희귀질환 및 알츠하이머 치료제에서 경쟁
- Eli LillyCompetitor
알츠하이머 치료제와 신경과학 파이프라인에서 직접 경쟁
ETFs holding this stock
Invesco Dynamic BioTech & Genome ETF · iShares Neuroscience and Healthcare ETF · The Free Markets ETF
Details →About Biogen
- What technical signals does Biogen (BIIB) have?
- Biogen current technical signals: Near 52-week high, VCP.
- Is Biogen a cup-and-handle pattern?
- No. Biogen has no valid Cup signal right now.
- What published figures are available for Biogen?
- Market cap: $32.26B. Trailing 12 months PER: 39.2×. Latest quarter PBR: 1.73×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Biogen, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).